Clinical Trials
Ascletis Reports Promising Preclinical Data for Once-Weekly Oral Obesity Treatments, Advances US Phase 1 Trial
Ascletis' industry-leading once-weekly oral peptide pipeline covers all four validated targets, with multiple first-in-class fixed-dose combina...
October 21, 2026 | News
AstraZeneca and Oracle Join Forces to Harness AI and Real-World Data for Smarter Clinical Trials
Collaboration to connect AstraZeneca's scientific and therapeutic expertise with Oracle's real-world data, cloud, AI, and clinical capabilities to accelera...
October 21, 2026 | News
PharmaEssentia Accelerates Global Expansion with US and Japan Drug Approvals and US$46 Million Manufacturing Investment
PharmaEssentia Corporation (TWSE: 6446), a Taiwan-based biopharmaceutical company, is expanding its global presence through new drug approvals, clini...
October 21, 2026 | News
Chipscreen Biosciences Secures China IND Approval for First-in-Class Cancer Immunotherapy NW001
Shenzhen Chipscreen Biosciences Co., Ltd. announced that NW001, a first-in-class epigenetic immune-modulating antibody conjugate (EIMAC) co-developed with ...
October 21, 2026 | News
Telix and Ekalia Join Forces to Scale Astatine-211 Production for Next-Generation Cancer Therapies in the US
Collaboration establishes a framework for a dedicated U.S. source of astatine-211 (211At), a scarce, next-generation alpha-emitting isotope with signific...
October 20, 2026 | News
How Long It Takes to Start a Clinical Trial in 8 APAC Markets, Timed
If you are building a 2027 trial budget this month, you are probably working from a spreadsheet with one row per country and a column headed "start-up". Mo...
October 19, 2026 | News
The PD-(L)1 x VEGF Bispecific Race: Every APAC Programme in the Clinic, Counted
When the ESMO Congress opens in Madrid on 23 October, one drug class will be hard to miss. Two days in, on the evening of Sunday 25 October, the Presidenti...
October 16, 2026 | Analysis
NueCell Bio Joins CIRM Partnership to Accelerate Cell and Gene Therapies from Discovery to GMP Readiness
NueCell Bio, a translational development partner that helps advance cell therapies from scientific discovery to GMP readiness, announced it has joined the ...
October 16, 2026 | News
China’s Hiteck Biological Pharma Licenses Next-Generation Eye Therapy to Visara for Global Development
Wuhan Hiteck Biological Pharma Co., Ltd. announced that it has entered into an exclusive license agreement (the "License Agreement") with Visara, Inc...
October 15, 2026 | News
Suvoda Expands Sofia AI Assistant Across New Clinical Trials to Accelerate Study Operations
Clinical trials require guard railed AI that's purpose built for the regulated industry that has high human stakes and required audit trails. Sofia help...
October 13, 2026 | News
South Korea’s GCCL and LabConnect Partner to Strengthen Global Clinical Trial Operations Across APAC and North America
GCCL, a South Korea-based leading global clinical trial central laboratory represented by CEO Kwan-goo Cho, announced today that it signed a Memorandum of ...
October 14, 2026 | News
Shanghai Ark Biopharmaceutical Secures US FDA IND Clearance for Phase II Trial of Long-Acting Influenza Prevention Drug AK0406
Shanghai Ark Biopharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted its investigational new drug (IND) application for AK...
October 14, 2026 | News
CellCarta Partners with Waters Corporation to Advance Companion Diagnostics and Next-Generation Flow Cytometry
CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, announced a strategic partnership with Waters Corporation, a global lea...
October 14, 2026 | News
360biolabs Expands Australian Footprint with New Bioanalytical Laboratory in Sydney
The new 360biolabs facility in North Ryde is strategically located within one of Sydney’s vibrant science and medtech hubs, Macquarie Park In...
October 14, 2026 | News
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
